Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00312286
Recruitment Status : Terminated (Lack of efficacy)
First Posted : April 10, 2006
Last Update Posted : September 23, 2016
Sponsor:
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2008
Actual Study Completion Date : June 2008
Certification/Extension First Submitted : September 12, 2016